Download Document

I.Статии в научни списания:
1. Kussovski, V., N.Cherepova, D.Veljanov: Ultrastructural characteristics of Salmonella
typhimurium during its physiological development. Biomedical Letters, 47, 1992, 383387.
2. Veljanov, D., T.Radoucheva, N.Cherepova, V.Kussovski, H.Najdenski: Biological
changes in digitonin-treated bacteria. Biomedical Letters, 48, 1993, 295-300.
3. Veljanov, D.K., A.M.Vesselinova, S.F.Nikolova, V.K.Kussovski, H.M.Najdenski:
Experimental infection with Yersinia pseudotuberculosis of ground squirrels (Citellus
citellus). J. Vet. Med., B, 40, 1993, 589-596.
IF- 0.513/1993
4. Markova, N., S.Nikolova, V.Kussovski, A.Vesselinova, D.Veljanov: Responsiveness
of susceptible inbred mice to Yersinia pseudotubrculosis serovar III infection. Zbl. Bakt.,
280, 1994, 360-370.
IF- 0.729/1994
5. Veljanov, D., V.Kussovski, T.Radoucheva, H.Najdenski, L.Ilieva, N.Cherepova,
K.Voivodov, N.Genov: Dark interaction of haematoporphyrin and proflavine with
Salmonella dublin cells. Cytobios, 79, 1994, 253-259.
6. Kussovski, V., T.Radoucheva, H.Najdenski, N.Cherepova: Haematoporphyrin and
proflavine-sensitized photoinactivation of Salmonella dublin. Cytobios, 84, 1995,157-169.
7. Veljanov, D., A.Vesselinova, S.Nikolova, H.Najdenski, V.Kussovski, N.Markova:
Experimental melioidosis in inbred mouse strains. Zbl. Bakt., 283, 1996, 351-359.
IF- 0.721/1996
8. Vesselinova, A., H.Najdenski, S.Nikolova, V.Kussovski: Experimental melioidosis in
hens. J.Vet.Med., B, 43, 1996, 371-378.
IF- 0.476/1996
9. Markova, N., T.Radoucheva, V.Kussovski: Influence of host and bacterial factors on
peritoneal cell response to Yersinia enterocolitica 0:3 in inbred mouse strains. Immunol.
Infect. Dis., 6, 1996, 81-85.
10.Markova, N., L.Michailova, A.Vesselinova, V.Kussovski, T.Radoucheva, S.Nikolova,
I.Paskaleva: Cell wall-deficient forms (L-forms) of Listeria monocytogenes in
experimentally infected rats. Zbl. Bakt., 286, 1997, 46-55.
IF- 0.733/1997
11.Markova, N., T.Radoucheva, V.Kussovski, K.Dilova, M.Shtarbova, I.Paskaleva:
Influence of blood transfusion on bactericidal activity of human leukocytes and sera
against Yersinia enterocolitica and Salmonella typhimurium. FEMS, Immunol. Med.
Microbiol., 19, 1998, 261-265.
IF- 1.075/1998
12.Markova, N., V.Kussovski, T.Radoucheva: Killing of Pseudomonas pseudomallei by
polymorphonuclear leukocytes and peritoneal macrophages from chicken, sheep, swine
and rabbits. Zbl. Bakteriol., 288, 1998, 103-110.
IF- 0.736/1998
13.Radoucheva,T., N.Markova, V.Kussovski, K.Dilova, A.Kril: Experimental Yersinia
enterocolitica 0:3 arthritis in rats. Clin. Microbiol. Infect., 5,1999, 47-48.
14.Radoucheva,T., N.Markova, V.Kussovski, K.Dilova, I.Paskaleva: The fate of Yersinia
pseudotuberculosis lipopolysaccharide (LPS) in intraperitoneally and intraarticularly
infected rats. Zent.bl. Bakteriol. 289, 1999, 135-145.
IF- 0.679/1999
15.Markova, N., T.Radoucheva, V.Kussovski, K.Dilova, I.Paskaleva, K.Veleva:
Persistence and in vivo effects of Yersinia enterocolitica O:3 endotoxin in rats. FEMS,
Immunol., Med. Microbiol, 24, 1999, 395-403.
IF- 1.329/1999
16.Michailova, L., N.Markova, T.Radoucheva, S.Stoitsova, V.Kussovski, M.Jordanova:
Atypical behaviour and survival of Streptococcus pyogenes L form during intraperitoneal
infection in rats. FEMS, Immunol., Med. Microbiol., 28, 2000, 55-65.
IF – 1.244/2000
17.Michailova, L., S.Stoitsova, N.Markova, V.Kussovski, M.Jordanova, I.Dimova:
Interaction of alveolar macrophages with Staphylococcus aureus and induction of
microbial L-forms during infection in rats. Int. J. Med. Microbiol., 290, 2000, 259-267.
IF – 0.599/2000
18.Kussovski,V.K., A.E.Hristov, T.S.Radoucheva: Proflavine-mediated inactivation of
Salmonella dublin exposed to visible sunlight in natural fresh water. Microbios, 105, 2001,
119-125.
IF – 0.405/2001
19.Markova N., V. Kussovski, T. Radoucheva, K.Dilova, N.Georgieva: Effects of
intraperitoneal and intranasal application of Lentinan on cellular response in rats.
Int.Immunopharmacol., 2, 2002, 1641-1645.
IF – 1.655/2002
20.Najdenski, H., V.Kussovski, Y.Michailov, A.Vesselinova: Protective effect of Oxadin®
on experimental Yersinia enterocolitica infection in rats. Pharmazie, 57, 2002, 5, 337-339.
IF – 0.74/2002
21.Markova N., V.Kussovski, I. Drandarska, S. Nikolaeva, N. Georgieva, T.Radoucheva.
Protective activity of Lentinan in experimental tuberculosis.Int.Immunopharmacol. 3,
2003, 1557-1562.
IF – 2.203/2003
22.Najdenski, H., V.Kussovski, A.Vesselinova. Experimental Burkholderia pseudomallei
infection of pigs. J. Vet. Med. B., 51, 2004, 225-230. IF – 1.182/2004
23.Drandarska, I., V.Kussovski, S. Nikolaeva, N. Markova. Combined immunomodulating
effects of BCG and Lentinan after intranasal application in guinea pigs. Int.
Immunopharmacol., 5, 2005, 795-803.
IF – 2.008/2005
24.Markova, N., L.Michailova, V. Kussovski, M. Jourdanova, T.Radoucheva. Intranasal
application of Lentinan enhances bactericidal activity of rat alveolar
macrophages
against Mycobacterium tuberculosis. Pharmazie, 60, 2005, 1, 42-48.
IF - 0.677/2005
25.Michailova L., Kussovski V., Radoucheva T., Jordanova M., Berger W., Rinder H.,
Markova N.: Morphological variability and cell-wall defficiency in Mycobacterium
tuberculosis “heteroresistant” strains. International Journal of Tuberculosis and Lung Disease,
9, 2005, 907–914.
IF – 1.456/2005
26.Najdenski H., E.Golkocheva, V. Kussovski, E. Ivanova, V. Manov, M.Iliev, A.
Vesselinova, J. Bengoechea, M. Skurnik. Experimental pig yersiniosis to assess attenuation
of Yersinia enterocolitica O:8mutant strains. FEMS Immunol Med Microbiol 47 (2006) 425–
435.
IF: 2.281/2006
27. Michailova L., V. Kussovsky, T. Radoucheva, M. Jordanova, N. Markova.Persistence of
Staphylococcus aureus L-form during experimental lung infection in rats. FEMS Microbiol
Lett 268 (2007) 88–97.
IF: 2.274/2007
28. Mantareva V., V. Kussovski, I. Angelov, E. Borisova, L. Avramov, G. Schnurpfeil, D.
Wöhrle. Photodynamic activity of water-soluble phthalocyanine zinc(II) complexes against
pathogenic microorganisms. Bioorganic & Medicinal Chemistry 15 (2007) 4829–4835
IF: 2.662/2007
29. Markova Nadya, Lilia Michailova, Vesselin Kussovski, Mimi Jourdanova.
Formation of persisting cell wall deficient forms of Mycobacterium bovis BCG during
interaction with peritoneal macrophages in guinea pigs. Electronic Journal of Biology, 2008,
Vol. 4(1): 1-10
30. Markova Nadya, Lilia Michailova, Mimi Jourdanova, Vesselin Kussovski, Violeta
Valcheva, Igor Mokrousov, Tatyana Radoucheva. Exhibition of persistent and drug-tolerant
L-form habit of Mycobacterium tuberculosis during infection in rats. Cent. Eur. J. Biol. 3(4)
2008 407–416
31. Najdenski H., E. Golkocheva-Markova, V. Kussovski, A. Vesselinova, S. Garbom &
H.Wolf-Watz (2008). Attenuation and Preserved Immunogenic Potential of Yersinia
pseudotuberculosis Mutant Strains Evidenced in Oral Pig Model. Zoonoses Public Health. 56
(2009) 157–168
IF: 1.478 /2007
32. Kussovski V., V. Mantareva, I. Angelov, P. Orozova, D. Wöhrle, G. Schnurpfeil, E.
Borisova & L. Avramov. Photodynamic inactivation ofAeromonas hydrophila by cationic
phthalocyanines with different hydrophobicity. FEMS Microbiol Lett 294 (2009) 133–140.
IF: 2.274 /2007
33. Kratchanova M., Mariana Nikolova, Elena Pavlova, Irina Yanakieva, Veselin Kussovski.
Composition and properties of biologically active pectic polysaccharides from leek (Allium
porrum). J Sci Food Agric (2010), DOI 10.1002/jsfa.4050
34. Mantareva V, I. Angelov, V. Kussovski, D. Woehrle, S. Dimitrov.
Metallophthalocyanines as photodynamic sensitizers for treatment of pathogenic bacteria:
Synthesis and singlet oxygen formation. Compt. rend. Acad. bulg. Sci., 62, 2009, 12, 15211526.
IF: 0.204 /2009
35. Mantareva V, I. Angelov, V. Kussovski, D. Woehrle, S. Dimitrov.
Metallophthalocyanines as photodynamic sensitizers for treatment of pathogenic bacteria:
Uptake and photoinactivation properties. Compt. rend. Acad. bulg. Sci., 63, 2010, 1, 77-84.
IF: 0.204 /2009
36. Kratchanova, M., M. Gocheva, E. Pavlova, I. Yanakieva, D. Nedelcheva, V. Kussovski,
A. Slavov. Characteristics of pectic polysaccharides from leek obtained through consecutive
extraction with various reaction agents. Bulg Chem Commun, 2008, 40, (4), 561-567.
37. Мантарева В, И.Ангелов, В.Късовски, С.Димитров. Фотодинамично-активни
комплекси за денталната медицина: състояние на проблема, развитие и перспективи.
Химия и индустрия 80 (2009) 1–7.
38. ВлаховаА., Хр. Кисов, Е. Попова, С. Димитров, В. Мантарева, И. Ангелов, В.
Късовски. Фотодинамичната терапия в денталната медицина. СДК и НУС 8, 2009, 3,
113-126.
Цитирания в международни издания
Veljanov, D., S.Nikolova, H.Najdenski, T.Radoucheva, V.Kussovski, I.Grigoriev, L.Ilieva:
Studies on aerosol Yersinia pseudotuberculosis infection of guinea-pigs. Acta microbiol.
bulg., 30, 1993, 3-10.
1. Fisher ML., C. Castillo, J. Mecsas. Intranasal Inoculation of Mice with Yersinia
pseudotuberculosis Causes a Lethal Lung Infection That Is Dependent on Yersinia Outer
Proteins and PhoP. Infect Immun, 75, 2007, 1, 429–442
Veljanov, D., A.Vesselinova, S.Nicolova, V.Kussovski, H. Najdenski, 1994. Experimental
Pseudomonas pseudomallei infection of pigs. Proc Int Congr Pig Vet Soc 13:236.
2. Taylor, D.J. Melioidosis (Burkholderia pseudomallei). In: Diseases of Swine, edited by B.
E. Straw. Edition: 9 Publisher: Blackwell Professional Publishing (2006), 618-619.
Veljanov,D.,A.Vesselinova,S.Nikolova,H.Najdenski,V.Kussovski, N.Markova:Experimental
melioidosis in inbred mouse strains. Zbl. Bakt., 283, 1996,351-359.
3. Cheng A.C, B. J. Currie: Melioidosis: Epidemiology, Pathophysiology, and anagement.
Clin. Microbiol.Rev. 18, 2005, 2, 383-416
4. Bottex, C., Y. P. Gauthier, R. M. Hagen, E. J. Finke, W. D. Splettstösser, F. M. Thibault,
H. Neubauer, D. R. Vidal: Attempted Passive Prophylaxis with a Monoclonal AntiBurkholderia Pseudomallei Exopolysaccharide Antibody in a Murine Model of Melioidosis.
Immunopharmacology and Immunotoxicology, 27, 2005, 4, 565-583
5. Lever MS., M. Nelson, AJ. Stagg, RJ. Beedham, AJH. Simpson. Experimental acute
respiratory Burkholderia pseudomallei infection in BALB⁄c mice. Int. J. Exp. Path. (2009), 90,
16–25
Vesselinova, A., H.Najdenski, S.Nikolova, V.Kussovski: Experimental melioidosis in hens.
J.Vet.Med., B, 43, 1996, 371-378.
6. Cheng A.C, B. J. Currie: Melioidosis: Epidemiology, Pathophysiology, and Management.
Clin. Microbiol.Rev. 18, 2005, 2, 383-416
7. Mahfouz, M. E., T.H. Grayson, D.A.B. Dance, M. L. Gilpin. Characterization of the
mrgRS locus of the opportunistic pathogen Burkholderia pseudomallei: temperature regulates
the expression of a two-component signal transduction system. BMC Microbiology 2006,
6:70.
8. Dance DAB. Melioidosis and glanders as possible biological weapons. In: Fong IW, Alibek
K, eds. Bioterrorism and infectious agents: a new dilemma for the 21st century. New York:
Springer, 2005; 99–143.
Markova, N., L.Michailova, A.Vesselinova, V.Kussovski, T.Radoucheva, S.Nikolova,
I.Paskaleva: Cell wall-deficient forms (L-forms) of Listeria monocytogenes in experimentally
infected rats. Zbl. Bakt., 286, 1997, 46-55
9. Colangeli, R., D. Helb, S. Sridharan, J. Sun, M. Varma-Basil, M. H. Hazbón, R.
Harbacheuski, N. J. Megjugorac, W. R. Jacobs Jr, A. Holzenburg, J. C. Sacchettini, D.
Alland: .The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump
that confers drug tolerance to both isoniazid and ethambutol. Molecular Microbiology, 55,
2005 (6), 1829-1840.
10. Beran, V., M. Havelkova, J. Kaustova, L. Dvorska, I. Palvik. Cell wall deficient forms of
mycobacteria: a review. Veterinarni Medicina, 51, 2006 (7): 365–389
Markova, N., V.Kussovski, T.Radoucheva: Killing of Pseudomonas pseudomallei by
polymorphonuclear leukocytes and peritoneal macrophages from chicken, sheep, swine and
rabbits. Zbl. Bakteriol., 288, 1998, 103-110.
11. Cheng A.C, B. J. Currie: Melioidosis: Epidemiology, Pathophysiology, and
Management. Clin. Microbiol.Rev. 18, 2005, 2, 383-416
12. Easton, A., A.Haque, K.Chu, R.Lukaszewski, G. J. Bancroft. A Critical Role for
Neutrophils in Resistance to Experimental Infection with Burkholderia pseudomallei. JID,
195, 2007, 99-107.
13. Mohapatra, N.P., A. Balagopal, S. Soni, L. S. Schlesinger, J. S. Gunn. AcpA is a
Francisella ascid phosphatase that affects intramacrophage survival and virulence.
INFECTION AND IMMUNITY, 75, 2007, 1, 390–396.
14. Mohapatra NP, Soni S, Reilly TJ, Liu JR, Klose KE, Gunn JS. Combined deletion of four
Francisella novicida acid phosphatases attenuates virulence and macrophage vacuolar escape.
INFECT IMMUN, 76, (8), 3690-3699, 2008
Michailova, L., N.Markova, T.Radoucheva, S.Stoitsova, V.Kussovski, M.Jordanova:
Atypical behaviour and survival of Streptococcus pyogenes L form during intraperitoneal
infection in rats. FEMS, Immunol., Med. Microbiol., 28, 2000, 55-65.
15. Colangeli, R., D. Helb, S. Sridharan, J. Sun, M. Varma-Basil, M. H. Hazbón, R.
Harbacheuski, N. J. Megjugorac, W. R. Jacobs Jr, A. Holzenburg, J. C. Sacchettini, D.
Alland: .The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump
that confers drug tolerance to both isoniazid and ethambutol. Molecular Microbiology, 55,
2005 (6), 1829-1840.
16. Wood, D. N, M. A. Chaussee, M. S. Chaussee, B. A. Buttaro: Persistence of
Streptococcus pyogenes in Stationary-Phase Cultures. J. Bacteriol. 187, 2005, 10, p. 3319–
3328
17. Sharma PK, Rakhorst G, Engels E, van der Mei HC, Busscher HJ, Ploeg RJ.
Microbubble-enriched lavage fluid for treatment of experimental peritonitis. BRIT J SURG,
95, (4), 522-529, 2008
18. Astrauskiene D, Bernotiene E. New insights into bacterial persistence in reactive arthritis
CLIN EXP DERMATOL, 25, (3), 470-479, 2007
19. Sharma P.K., E.Engels, W.Van Oeveren, R. J. Ploeg, C. van Henny derMei, H.
J.Busscher, G.M.Van Dam, G. Rakhorst. Spatiotemporal progression of localized bacterial
peritonitis before and after open abdomen lavage monitored by in vivo bioluminescent
imaging. Surgery, 2010, 147, 1, 89-97.
Michailova, L., S.Stoitsova, N.Markova, V.Kussovski, M.Jordanova, I.Dimova:
Interaction of alveolar macrophages with Staphylococcus aureus and induction of microbial
L-forms during infection in rats. Int. J. Med. Microbiol., 290, 2000, 259-267.
20. Kubica, M., K.Guzik, J. Koziel, M. Zarebski, W. Richter, B. Gajkowska, A.Golda, A.
Maciag-Gudowska, K. Brix, L. Shaw, T. Foster, J. Potempa. A Potential New Pathway
for Staphylococcus aureus Dissemination: The Silent Survival of S. aureus Phagocytosed by
Human Monocyte-Derived Macrophages. PLoS ONE, 3 (1), Jan 2008
21. Miller M., S. Donat, S. Rakette, T. Stehle, T. R. H. M. Kouwen, S. H. Diks, A. Dreisbach,
E. Reilman, K. Gronau, D. Becher, M. P. Peppelenbosch, J. M. van Dijl, K. Ohlsen.
Staphylococcal PknB as the first prokaryotic representative of the proline-directed kinases.
PLoS ONE | www.plosone.org, 2010, 5, 2, e9057
Kussovski,V.K., A.E.Hristov, T.S.Radoucheva: Proflavine-mediated inactivation of
Salmonella dublin exposed to visible sunlight in natural fresh water. Microbios, 105, 2001,
119-125.
22. Langner, K. Modelowanie oddziaływan ligandów aromatycznych z kwasami
nukleinowymi. Praca Magisterska. Politechnika Wrocławska. Wrocław 2005
23. Reed, R.H. The inactivation of microbes by sunlight: Solar disinfection as a water
treatment process. Adv. Appl. Microbiol. 54, 2004, 333-365
24. Herkovits, J., Pérez-Coll, C.S., Stockert, J.C., Blázquez, A. The screening of
photodynamic toxicity of dyes by means of a bioassay using amphibian embryos. Research
Journal of Chemistry and Environment. 11, 2007, 1, 86-91.
25. Darcan C, Ozkanca R, Idil O, Flint KP. Viable but non-culturable state (VBNC) of
Escherichia coli related to EnvZ under the effect of pH, starvation and osmotic stress in sea
water. Polish J Microbiol, 58, 2009, 4, 307-317.
26. Önder İdil, Reşit Özkanca, Cihan Darcan and Ken P. Flint. Escherichia coli: Dominance
of red light over other visible light sources in establishing viable but nonculturable state.
Photochemistry and Photobiology, 2010, 86: 104–109.
Markova N., V. Kussovski, T. Radoucheva, K.Dilova, N.Georgieva: Effects of
intraperitoneal and intranasal application of Lentinan on cellular response in rats.
Int.Immunopharmacol., 2, 2002, 1641-1645.
27. XIE Hongqi ZHOU Chunshan. Study on de-colorization technology of Lentinan. ION
EXCHANGE AND ADSORPTION, 2007, 23 (2) :158-165
Markova N., V.Kussovski, I. Drandarska, S. Nikolaeva, N. Georgieva, T.Radoucheva.
Protective activity of Lentinan in experimental tuberculosis. Int.Immunopharmacol. 3, 2003,
1557-1562.
28. Lull C., H. J. Wichers, H. F. J. Savelkoul. Antiinflammatory and Immunomodulating
Properties of Fungal Metabolites. Mediators of Inflammation, 2, 2005, 63–80
29. Kupfahl C., G. Geginat, H. Hof. Lentinan has a stimulatory effect on innate and adaptive
immunity against murine Listeria monocytogenes infection. International
Immunopharmacology, 6, 2006, 686– 696
30. CHOVANCOVÁ, A., E. ŠTURDÍK. VPLYV BETA-GLUKÁNOV NA IMUNITNÝ
SYSTÉM ČLOVEKA. Nova Biotechnologica V-I (2005) 105- 121.
31. Wang, W., Dai, X., Ouyang, X. Efficacy of Lentinan combined with chemotherapy in
advanced non-small cell lung cancer.Chinese Journal of Lung Cancer, 9, 2006, 1, 78-81.
32. Dong, S.-F., Chen, J.-M., Zhang, W., Sun, S.-H., Wang, J., Gu, J.-X., Boraschi, D., Qu, D.
Specific immune response to HBsAg is enhanced by β-glucan oligosaccharide containing an
α-(1 → 3)-linked bond and biased towards M2/Th2. International Immunopharmacology, 7,
2007, 6, June, 725-733
33. Chen, J., R. Seviour. Medicinal importance of fungal β- (1→3), (1→6)-glucans. MYCOL
RES, 111, (6), 635-652, 2007
34. Zjawiony JK. Antitubercular activity of mushrooms (Basidiomycetes) and their
metabolites. NAT PROD COMMUN, 2, (3), 315-318, 2007
35. Zhou L., Q.Zhang, Y. Zhang, J. Liu, Y. Cao. The shiitake mushroom-derived immunostimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive
immune-responses. International Immunopharmacology 9 (2009) 455–462
36. D. Wang, Z. Guo, X. Ma, Y. Hu, X. Huang, Y. Fan, S. Yang, L. Guo. Effects of sulfated
lentinan on cellular infectivity of avian infectious bronchitis virus. Carbohydrate Polymers 79
(2010) 461–465
37. Savelkoul H., C. Nogiera, H. Wichers. Immunomodulation by dietary
mushroomcompounds.\http://www.old-herborn
university.de/literature/books/OHUni_book_20_article_4.pdf. 37-62.
38. Wang J. , Sheng-Fu Dong , Chun-hong Liu , Wei Wang, Shu-Hui Sun , Jian-xin Gu ,
-glucan oligosaccharide enhances CD8+ T cells
immune response induced by a DNA vaccine encoding hepatitis B virus core antigen.
http://www.hindawi.com/journals/jbb/aip.645213.pdf
39. Christophersen O.A. , A. Haug. More about hypervirulent avian influenza: Is the world
now better prepared? Microbial Ecology in Health and Disease 19, 2007, 2, 78-121.
40. SHI Xing, DING Qian, YANG Qing. Lentinan Combined with Chemotherapy in the
Treatment of Advanced Non-small Cell Lung Cancer. BULLETIN OF CHINESE CANCER,
16, 2007, 11, 946-948.
41. Shah VB. Molecular and functional analysis of beta-glucan-mediated microglial
activation. Thesis PhD. 2009. The Ohio State University. Columbus, Ohio,USA.
Najdenski, H., V.Kussovski, A.Vesselinova. Experimental Burkholderia pseudomallei
infection of pigs. J. Vet. Med. B., 51, 2004, 225-230.
42. Keluangkhot, V., R. Pethsouvanh, M. Strobel. Melioidosis. Médecine et maladies
infectieuses 35 (2005) 469–475
43. Boddey, Justin Andrew 2005. Molecular and cellular characterisation of Burkholderia
pseudomallei interactions with host cells. Thesis PhD.Griffith University. Gold coast.
Queensland.
44. van Schaik E, Tom M, DeVinney R & Woods DE (2008) Development of novel animal
infection models for the study of acute and chronic Burkholderia
pseudomallei pulmonary infections. Microbes Infect 2008 10(12-13):1291-9.
45. Bondi SK, Goldberg JB: Strategies toward vaccines against Burkholderia mallei and
Burkholderia pseudomallei. EXPERT REV VACCINES, 7, (9), 1357-1365, 2008
Drandarska, I., V.Kussovski, S. Nikolaeva, N. Markova. Combined immunomodulating
effects of BCG and Lentinan after intranasal application in guinea pigs. Int.
Immunopharmacol., 5, 2005, 795-803.
46. Schwartz, Y. S., M. I. Dushkin, V. A. Vavilin, E. V. Melnikova, O. M. Khoschenko, V.
A. Kozlov,A. P. Agafonov, A. Y. Alekseev, Y. Rassadkin, A. M. Shestapalov, M. S. Azaev,
D. V. Saraev, P. N. Filimonov, Y. Kurunov, A. V. Svistelnik, V. A. Krasnov, A. Pathak, S. C.
Derrick, R. C. Reynolds, S. Morris, V. M. Blinov. Novel Conjugate of Moxifloxacin and
Carboxymethylated Glucan with Enhanced Activity against Mycobacterium tuberculosis.
Antimicrob. Agents Chemother, 50 2006, 6, 1982–1988.
47. Garcia-Contreras, L., V. Sethuraman, M. Kazantseva, V. Godfrey, A. J. Hickey.
Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the
treatment of tuberculosis in the guinea pig. Journal of Antimicrobial Chemotherapy, 58, 2006,
980–986.
48. Garcia-Contreras, L., J. Fiegel, M. J. Telko, K. Elbert, A. Hawi, M. Thomas, J.
VerBerkmoes, W. A. Germishuizen, P. B. Fourie, A. J. Hickey, D. Edwards. Inhaled large
porous particles of capreomycin for treatment of tuberculosis in a guinea pig model.
Antimicrob. Agents Chemother., 51, 2007, 8, 2830–2836.
49. Li, W.-L., Song, Y.-M. Establishment of the guinea pig model of synovial tuberculosis of
knee joint by mycobacterium tuberculosis H37Rv infection. Journal of Sichuan University
(Medical Science Edition),37, 2006, 5, 804-806
50. Dong, S.-F., Chen, J.-M., Zhang, W., Sun, S.-H., Wang, J., Gu, J.-X., Boraschi, D., Qu, D.
Specific immune response to HBsAg is enhanced by β-glucan oligosaccharide containing an
α-(1 → 3)-linked bond and biased towards M2/Th2. International Immunopharmacology, 7,
2007, 6, June, 725-733
51. Soltanian, S. (2007) Protection of gnotobiotic Artemia against Vibrio
campbellii using baker’s yeast strains and extracts. PhD thesis, Ghent
University, Belgium.
52. Soltanian, S., Stuyven, E., Cox, E., Sorgeloos, P., Bossier, P. Beta-glucans as
immunostimulant in vertebrates and invertebrates. CRITICAL REVIEWS IN
MICROBIOLOGY 35 2009, 2, 109-138.
53. Cho H, R.de Haas, A. Jeevan, D. McMurray. Differential activation of alveolar and
peritoneal macrophages from BCG-vaccinated guinea pigs. Tuberculosis, 88, 2008, 4, 307316.
54. Stuyven, E., Cox, E., Vancaeneghem, S., Arnouts, S., Deprez, P., Goddeeris, B.M., Effect
of β-glucans on an ETEC infection in piglets, Veterinary Immunology and
Immunopathology,128, 2009, 1-3, Sp. Iss., 60-66.
55. Chen JZ, Seviour R: Medicinal importance of fungal β- (1→ 3), (1→ 6) -glucans.
MYCOL RES, 111, (6), 635-652, 2007
56. Zjawiony JK. Antitubercular activity of mushrooms (Basidiomycetes) and their
metabolites. NAT PROD COMMUN, 2, (3), 315-318, 2007
57. Djordjevic B, Škugor S, Jørgensen SM, Øverland M, Mydland LT, Krasnov A (2008).
Modulation of splenic immune responses to bacterial lipopolysaccharide in rainbow trout
(Oncorhynchus mykiss) fed lentinan, a beta-glucan from mushroom Lentinula edodes. Fish &
Shellfish Immunology 26, 2009, 2, 201-209.
58. Garcia-Contreras L., J. C. Sung, P. Muttil, D. Padilla, M. Telko, J. L. VerBerkmoes, K. J.
Elbert, A. J. Hickey, D. A. Edwards. Dry Powder PA-824 Aerosols for Treatment of
Tuberculosis in Guinea Pigs. Antimicrob. Agents Chemother., 54, 2010, 4, 1436–1442.
59. Busch E., Von Rekowski, RW., Mölleken, H. Edible mushrooms and their medicinally
effective extracts. Zeitschrift fur Phytotherapie, 28, 2007, 3, 115-124.
Markova, N., L.Michailova, V. Kussovski, M. Jourdanova, T.Radoucheva. Intranasal
application of Lentinan enhances bactericidal activity of rat alveolar
macrophages
against Mycobacterium tuberculosis. Pharmazie, 60, 2005, 1, 42-48.
60. Chen, J., R. Seviour. Medicinal importance of fungal β- (1→3), (1→6)-glucans. MYCOL
RES, 111, (6), 635-652, 2007
61. Soltanian S., E. Stuyven, E. Cox, P. Sorgeloos, P. Bossier. Beta-glucans as
immunostimulant in vertebrates and invertebrates. Critical Reviews in Microbiology 2009, 35,
2, 109-138.
62. SHEN J., WANG S., QI Y., GAO Y. HANG Z., QIU L. Comparing the Lentinan Yield of
the Monokaryontic Mycelia to the Dikaryotic Mycelia from Lentinula edodes 939.
Horticultural Science, 2007, 34 (4), 941—946
63. Christophersen O.A. , A. Haug. More about hypervirulent avian influenza: Is the world
now better prepared? Microbial Ecology in Health and Disease 19, 2007, 2, 78-121.
64. Shah VB. Molecular and functional analysis of beta-glucan-mediated microglial
activation. Thesis PhD. 2009. The Ohio State University. Columbus, Ohio,USA.
Michailova L., Kussovski V., Radoucheva T., Jordanova M., Berger W., Rinder H., Markova
N.: Morphological variability and cell-wall defficiency in Mycobacterium tuberculosis
“heteroresistant” strains. International Journal of Tuberculosis and Lung Disease, 9, 2005,
907–914.
65. Beran, V., M. Havelkova, J. Kaustova, L. Dvorska, I. Palvik. Cell wall deficient forms of
mycobacteria: a review. Veterinarni Medicina, 51, 2006 (7): 365–389
66. Елисеева И.В., Бабич Е.М., Волянский Ю.Л., Скляр Н.И., Белозерский В.И. О роли
латентных, трудно культивируемых и некультивируемых персистентных бактерий в
патологии человека. Анали Мечниковського Інституту, АМН Украины, Харьков, N 1,
2006, 12-46.
67. Schneider, P. Über die Bedeutung zellwandfreier Bakterienformen (CWD) auch in Bezug
auf (Para-) Tuberkulose, Morbus Crohn und BSE. In: Gedanken altern nicht, edited by Peter
Schneider, Ausgabe 2006, Verlag: Books on Demand.
68. Allan EJ, Hoischen C, Gumpert J. Bacterial L-Forms. ADV APPL MICROBIOLOGY,
68, 2009 1-39.
69. Malhotra S., N K. Bhatia, M. Kaushal, N. Kaur and A. Chauhan. Pleomorphic appearance
in Mycobacterium tuberculosis. Journal of Public Health and Epidemiology, 2, 2010 (2), 1112.
70. Zhu Ming-li. Diagnostic value of L-forms and large bodies of mycobacterium tuberculosis
in patients with pulmonary tuberculosis. CHINESE JOURNAL OF HEALTH
LABORATORY TECHNOLOGY 2007, 12, 2174-2176.
Najdenski H., E.Golkocheva, V. Kussovski, E. Ivanova, V. Manov, M.Iliev, A.Vesselinova,
Jos ´e Antonio Bengoechea, M. Skurnik. Experimental pig yersiniosis to assess attenuation
ofYersinia enterocolitica O:8mutant strains. FEMS Immunol Med Microbiol 47 (2006) 425–
435.
71. Leibiger Robert, Katy Niedung, Gernot Geginat, Jürgen Heesemann & Konrad Trülzsch.
Yersinia enterocolitica Yop mutants as oral live carrier vaccines. Vaccine 26, 2008, 51, 66646670.
72. Bartra S. C. S. Outer Membrane Proteins of Yersinia pestis Ail and OmpA. Thesis PhD.
Institutionen för Molekylärbiologi, UMEÅ UNIVERSITET, 901 87 Umeå,Umeå 2010
Michailova L., V. Kussovsky, T. Radoucheva, M. Jordanova, N. Markova.Persistence of
Staphylococcus aureus L-form during experimental lung infection in rats. FEMS Microbiol
Lett 268 (2007) 88–97.
73. Hübscher, J., Jansen, A., Kotte, O., Schäfer, J., Majcherczyk, P.A., Harris, L.G.,
Bierbaum, G., Heinemann, M., Berger-Bächi, B. Living with an imperfect cell wall:
Compensation of femAB inactivation in Staphylococcus aureus. BMC Genomics 2007, 8:307,
doi:10.1186/1471-2164-8-30707
74. Nackerdien, ZE. Perspectives on microbes as oncogenic infectious agents and
implications for breast cancer. Medical Hypotheses, 71, 2008, 2, 302-306.
75. Sayed SM, GA Abou El-Ella, NM Wahba, NA El Nisr, K Raddad, MF Abd El Rahman,
M.M. Abd El Hafeez, A Abd El Fattah Aamer. Immune defense of rats immunized with
fennel honey, propolis, and bee venom against induced staphylococcal infection. Journal of
Medicinal Food, 12, 2009, 3, 569-575.
Mantareva V., V. Kussovski, I. Angelov, E. Borisova, L. Avramov, G. Schnurpfeil,
D.Wöhrle. Photodynamic activity of water-soluble phthalocyanine zinc(II) complexes against
pathogenic microorganisms. Bioorganic & Medicinal Chemistry 15 (2007) 4829–4835
76. Josefsen LB & Boyle RW (2008) Photodynamic Therapy and the Development of MetalBased Photosensitisers. Metal-Based Drugs Volume 2008, Article ID 276109, 24 pages
77. Cormick MP, Alvarez MG, Rovera M, & Durantini EN (2008) Photodynamic
inactivation of Candida albicans sensitized by tri- and tetra-cationic porphyrin derivatives.
Eur J Medic Chemistry 44 (2009) 1592–1599.
78. Moody L.M. & A. A. Holder. Inorganic pharmaceuticals. Annu. Rep. Prog. Chem.,
Sect. A, 2008, 104, 477–497
79. Seven O, Dindar B, Aydemir S, Cilli F. Synthesis, properties and photodynamic
activities of some zinc(II) phthalocyanines against Escherichia coli and Staphylococcus
aureus J PORPHYR PHTHALOCYA., 12, 8, 953-963, 2008
80. Spesia M. B., D.A. Caminos, P. Pons,E. N. Durantini. Mechanistic insight of the
photodynamic inactivation of Escherichia coli by a tetracationic zinc(II) phthalocyanine
derivative. Photodiagnosis and Photodynamic Therapy (2009)
81. Song Z.-C., G.-Y. Ma, P.-C. Lv, H.-Q. Li, Z.-P. Xiao, H.-L. Zhu. Synthesis, structure and
structure–activity relationship analysis of 3-tert-butoxycarbonyl- 2-arylthiazolidine-4carboxylic acid derivatives as potential antibacterial agents. European Journal of Medicinal
Chemistry 44 (2009) 3903–3908.
82. Funes M., D. Caminos, M. Alvarez, F. Fungo, L. Otero, E. Durantini. Photodynamic
Properties and Photoantimicrobial Action of Electrochemically Generated Porphyrin
Polymeric Films. Environ. Sci. Technol., 2009, 43 (3), 902-908
83. de Oliveira KT., FF. de Assis, AO. Ribeiro, CR. Neri, AU. Fernandes, MS. Baptista, NP.
Lopes, OA. Serra,Y. Iamamoto Synthesis of phthalocyanines-ALA conjugates: watersoluble compounds with low aggregation. J. Org. Chem. 2009, 74, 7962–7965.
84. Strassert CA, M Otter, RQ Albuquerque, A Hone, Y Vida, B Maier, L De Cola.
Photoactive hybrid nanomaterial for targeting, labeling, and killing antibiotic-resistan
bacteria. Angewandte Chemie, 48, (2009), 42, 7928-7931.
85. Chen, W., Liu, F., Lü, W., Shen, X., Yao, Y., Xu, M. Preparation and photoactivity of
thermosensitive polymer supported metallophthalocyanine. Science in China, Series B:
Chemistry, Volume 51, (2008), 6, 570-576.
86. Stochel G., Z. Stasicka, M. Brindell, W. Macyk, K. Szacilowski. Bioinorganic
Photochemistry. Published by John Wiley and Sons, 2009.
87. Zimcik, P. M. Miletin, H. Radilova, V. Novakova, K. Kopecky, J. Svec, E. Rudolf.
Synthesis, properties and in vitro photodynamic activity of water-soluble azaphthalocyanines
and azanaphthalocyanines. Photochemistry and Photobiology, 2010, 86: 168–175.
88. Giuliani F., M. Martinelli, A. Cocchi, D.Arbia, L. Fantetti, G. Roncucci. In vitro
resistance selection studies of RLP068/Cl, a new Zn(II)phthalocyanine suitable for
Antimicrobial PhotoDynamic Therapy (APDT). Antimicrob. Agents Chemother.
doi:10.1128/AAC.00603-09, 54, 2010, 2, 637-642.
89. Smolinská M., P. Olejníková, D. Hudecová, G. Čík. Photodynamic inactivation of
Escherichia coli by methylene blue incorporated in ZSM-5 zeolite channels under red LED
light. Acta Chimica Slovaca, Vol.3, No.1, 2010, 41 – 50.
90. Ogunbayo T.B., T. Nyokong. Photophysical and photochemical properties of Ni(II),
Pd(II) and Pt(II) aryloxo and alkylthio derivatised phthalocyanine. Journal of Molecular
Structure, (2010) doi:10.1016/j.molstruc.2010.03.047.
91. Ryskova L., V. Buchta, R. Slezak. Photodynamic Antimicrobial Therapy. Cent.
Eur. J. Biol. 2010, DOI: 10.2478/s11535-010-0032-2.
92. Omar GSM. Killing of organisms responsible for wound infections using a light-activated
antimicrobial agent. PhD thesis. Dental Institute ,University College London 2010, United
Kingdom.
93. Huang L., T. Dai, M. R. Hamblin. Antimicrobial photodynamic inactivation and
photodynamic therapy for infections. In: Photodynamic Therapy, Methods in Molecular
Biology, 635, 2010, 155- 173, ed. C.J.Gomer, Publ. “Humana Press”.
Junqueira J.C., M.A. Ribeiro, R.D. Rossoni, J.O. Barbosa, S.M.R. Querido, A.O.C. Jorge.
Antimicrobial Photodynamic Therapy: Photodynamic Antimicrobial Effects of Malachite
Green on Staphylococcus, Enterobacteriaceae, and Candida. Photomedicine and Laser
Surgery 28, 2010, Suppl. 1, S67–S72.
Kussovski V., V. Mantareva, I. Angelov, P. Orozova, D. Wöhrle, G. Schnurpfeil, E. Borisova
& L. Avramov. Photodynamic inactivation ofAeromonas hydrophila by cationic
phthalocyanines with different hydrophobicity. FEMS Microbiol Lett 294 (2009) 133–140.
94. Dai T., L. Huang, MR Hamblin. Photodynamic therapy for localized Infections –
State of the art. Photodiagnosis and Photodynamic Therapy 6, (2009), 170—188.
95. Dumoulin F., M. Durmus¸, V. Ahsen, T. Nyokong, Synthetic pathways to water-soluble
phthalocyanines and close analogs, Coordination Chemistry Reviews (2008),
doi:10.1016/j.ccr.2010.05.002